Aclarion's CEO Brent Ness to Attend LSI USA 2026 Conference
ByAinvest
Thursday, Mar 12, 2026 6:02 am ET1min read
ACON--
Aclarion CEO Brent Ness will attend LSI USA 2026 to discuss the company's progress on NOCISCAN, a proprietary MR spectroscopy platform that uses AI and biomarkers to help physicians identify the source of chronic low back pain. The platform distinguishes between painful and non-painful discs, giving physicians clarity to optimize treatment strategies. The conference is a premier event focused on accelerating MedTech and HealthTech innovation, bringing together investors, startups, and industry leaders.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet